e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
Andrew D. Kerkhoff, Bianca Sossen, Charlotte Schutz, Elena Ivanova Reipold, Andre Trollip, Emmanuel Moreau, Samuel G. Schumacher, Rosie Burton, Amy Ward, Mark P. Nicol, Graeme Meintjes, Claudia M. Denkinger, Tobias Broger
Source:
Eur Respir J, 55 (2) 1901259; 10.1183/13993003.01259-2019
Journal Issue:
February
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andrew D. Kerkhoff, Bianca Sossen, Charlotte Schutz, Elena Ivanova Reipold, Andre Trollip, Emmanuel Moreau, Samuel G. Schumacher, Rosie Burton, Amy Ward, Mark P. Nicol, Graeme Meintjes, Claudia M. Denkinger, Tobias Broger. Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV. Eur Respir J, 55 (2) 1901259; 10.1183/13993003.01259-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Expert interview: Microbiologists on tuberculosis diagnostics
Related content which might interest you:
Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients
Source: Eur Respir J 2012; 40: 1211-1220
Year: 2012
Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2012; 39: 163-171
Year: 2012
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2011; 39: 163-171
Year: 2012
A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay
Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018
Year: 2019
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying
mycobacterium tuberculosis
during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India
Source: Eur Respir J 2014; 44: 1090-1093
Year: 2014
Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of tuberculosis in HIV patients; Egyptian experience
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
Source: Eur Respir J, 58 (5) 2003999; 10.1183/13993003.03999-2020
Year: 2021
Diagnosis of latent tuberculosis infection (LTBI) by quantiFERON®-TB gold test – QFT in homeless people in Poland
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Evaluation of the QuantiFERON-TB Gold in tube cut-off for diagnosing tuberculosis in HIV-infected and non-HIV infected individuals
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept